← Leaderboards
Charlotte Avanzi
Colorado State University
$904,384
Attributed
$904,384
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $362.9K · FY2022–24$500K$375K$250K$125K$0
'22
'23
'24
Funding mix
By agency
NIH$904,384 · 3
By mechanism
R21$813,625 · 2
R03$90,759 · 1
Top collaborators
No co-investigators on record.
Most similar at Colorado State University
Same institution · by research overlap
- Richard Bryan McCosh$1,058,517
- Jozsef Vigh$3,792,392
- Reagan Pennock$257,001
- Brent Philip Myers$4,265,598
- Bettina Broeckling$77,097
Others in their field
Other Rising Stars on “Bacteria”
- Urs Oschner · Crestone, Inc.$8,499,692
- Rick L. Stevens · University Of Chicago$7,200,000
- Brian Kane · Spero Therapeutics, Inc.$6,712,318
- Andrew Tomaras · Forge Therapeutics, Inc.$6,265,409
- Louisa Smieska · Cornell University$4,999,825
- Ralf Lenigk · Ge Medical Systems Information Technologies, Inc$4,211,973
Research focus
BacteriaMycobacterium LepraeLeprosySuccessPreventDrug ResistanceMolecularIn VitroPharmaceutical PreparationsPharmacotherapyWeaponsMolecular MarkerMonitorWorld Health OrganizationTreatment FailureFightingRegimenRifampinInfectionMycobacterium TuberculosisVaccinesBacterial DnaRecombinantsBacillus
Grant awards (5)
Mechanism of action of Dapsone in Mycobacterium leprae$231,000
R21 · FY2024 · AI · contact PI
New approaches to sequence genomes of Mycobacterium leprae from clinical and field specimens$90,759
R03 · FY2024 · AI · contact PI
Mechanism of action of Dapsone in Mycobacterium leprae$191,927
R21 · FY2023 · AI · contact PI
Monitoring Treatment Efficacy in Leprosy$171,012
R21 · FY2023 · AI · contact PI
Monitoring Treatment Efficacy in Leprosy$219,686
R21 · FY2022 · AI · contact PI